Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Climb Bio, Inc.

Climb Bio Expands Pipeline Through an Exclusive License to Develop and Commercialize an Antibody Targeting the APRIL Pathway for IgA Nephropathy
From Climb Bio, Inc.
Via GlobeNewswire
Tickers CLYM
Climb Bio to be Added to the Nasdaq Biotechnology Index
From Climb Bio, Inc.
Via GlobeNewswire
Tickers CLYM
Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights
From Climb Bio, Inc.
Via GlobeNewswire
Tickers CLYM
Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board
From Climb Bio, Inc.
Via GlobeNewswire
Tickers CLYM
Climb Bio to Present at Upcoming Investor Conferences
From Climb Bio, Inc.
Via GlobeNewswire
Tickers CLYM
Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event
From Climb Bio, Inc.
Via GlobeNewswire
Tickers CLYM
Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024
From Climb Bio, Inc.
Via GlobeNewswire
Tickers CLYM
Climb Bio to Present at William Blair’s Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19
From Climb Bio, Inc.
Via GlobeNewswire
Tickers CLYM
Climb Bio to Host Virtual Investor Event on October 15, 2024
From Climb Bio, Inc.
Via GlobeNewswire
Tickers CLYM
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.